October 14, 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (“Inventiva ” or the “Company ”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the ...
October 14, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback